An increase in acid resistance of foot-and-mouth disease virus capsid is mediated by a tyrosine replacement of the VP2 histidine previously associated with VP0 cleavage

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 3039-3042

  Vázquez Calvo, Angela ^a   Caridi, Flavia ^a   Sobrino, Francisco ^a,b   Martín Acebes, Miguel A ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Consejo Superior de Investigaciones Científicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; HISTIDINE; PROTEIN VP0; PROTEIN VP1; PROTEIN VP2; TYROSINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROCESSING; SENSITIVITY ANALYSIS; VIRUS CAPSID; VIRUS ISOLATION; VIRUS RESISTANCE;

AMINO ACID SUBSTITUTION; ANIMALS; CAPSID PROTEINS; CELL LINE; CRICETINAE; FOOT-AND-MOUTH DISEASE VIRUS; HISTIDINE; HYDROGEN-ION CONCENTRATION; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEOLYSIS; TYROSINE;

EID: 84896720519     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03222-13     Document Type: Article

References (26)

1. Sobrino F, Domingo E. 2001. Foot-and-mouth disease in Europe. FMD is economically the most important disease of farm animals. Its reemergence in Europe is likely to have consequences that go beyond severe alterations of livestock production and trade. EMBO Rep. 2:459-461. http://dx.doi.org/10.1093/embo-reports/kve122.
2. Grubman MJ, Baxt B. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493. http://dx.doi.org/10.1128/CMR.17.2.465-493.2004.
3. Vasquez C, Denoya CD, La Torre JL, Palma EL. 1979. Structure of foot-and-mouth disease virus capsid. Virology 97:195-200. http://dx.doi .org/10.1016/0042-6822(79)90387-8.
4. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 337:709-716. http://dx.doi.org/10.1038/337709a0.
5. Lea S, Hernandez J, Blakemore W, Brocchi E, Curry S, Domingo E, Fry E, Abu-Ghazaleh R, King A, Newman J, Stuart D, Mateu MG. 1994. The structure and antigenicity of a typeCfoot-and-mouth disease virus. Structure 2:123-139. http://dx.doi.org/10.1016/S0969-2126(00)00014-9.
6. Baxt B. 1987. Effect of lysosomotropic compounds on early events in foot-and-mouth disease virus replication. Virus Res. 7:257-271. http://dx .doi.org/10.1016/0168-1702(87)90032-3.
7. Berryman S, Clark S, Monaghan P, Jackson T. 2005. Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus. J. Virol. 79:8519-8534. http://dx.doi.org/10.1128/JVI.79.13.8519-8534 .2005.
8. O'Donnell V, LaRocco M, Duque H, Baxt B. 2005. Analysis of foot-andmouth disease virus internalization events in cultured cells. J. Virol. 79: 8506-8518. http://dx.doi.org/10.1128/JVI.79.13.8506-8518.2005.
9. Martín-Acebes MA, Rincón V, Armas-Portela R, Mateu MG, Sobrino F. 2010. A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to aciddependent uncoating inhibition. J. Virol. 84:2902-2912. http://dx.doi.org /10.1128/JVI.02311-09.
10. Martín-Acebes MA, Vázquez-Calvo A, Rincón V, Mateu MG, Sobrino F. 2011. A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid resistance. J. Virol. 85:2733-2740. http://dx .doi.org/10.1128/JVI.02245-10.
11. Liang T, Yang D, Liu M, Sun C, Wang F, Wang J, Wang H, Song S, Zhou G, Yu L. 12 October 2013. Selection and characterization of an acid-resistant mutant of serotype O foot-and-mouth disease virus. Arch. Virol. http://dx.doi.org/10.1007/s00705-013-1872-7.
12. Toja M, Escarmis C, Domingo E. 1999. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Virus Res. 64:161-171.
13. García-Arriaza J, Manrubia SC, Toja M, Domingo E, Escarmís C. 2004. Evolutionary transition toward defective RNAs that are infectious by complementation. J. Virol. 78:11678-11685. http://dx.doi.org/10.1128/JVI.78 .21.11678-11685.2004.
14. Hindiyeh M, Li QH, Basavappa R, Hogle JM, Chow M. 1999. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J. Virol. 73:9072-9079.
15. Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Stuart D. 1997. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J. Virol. 71:9743-9752.
16. Basavappa R, Syed R, Flore O, Icenogle JP, Filman DJ, Hogle JM. 1994. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci. 3:1651-1669. http://dx.doi.org/10.1002/pro .5560031005.
17. Twomey T, France LL, Hassard S, Burrage TG, Newman JF, Brown F. 1995. Characterization of an acid-resistant mutant of foot-and-mouth disease virus. Virology 206:69-75. http://dx.doi.org/10.1016/S0042-6822(95)80020-4.
18. van Vlijmen HW, Curry S, Schaefer M, Karplus M. 1998. Titration calculations of foot-and-mouth disease virus capsids and their stabilities as a function of pH. J. Mol. Biol. 275:295-308. http://dx.doi.org/10.1006 /jmbi.1997.1418.
19. Ellard FM, Drew J, Blakemore WE, Stuart DI, King AM. 1999. Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids. J. Gen. Virol. 80(Pt 8):1911-1918.
20. Li H, Robertson AD, Jensen JH. 2005. Very fast empirical prediction and rationalization of protein pKa values. Proteins 61:704-721. http://dx.doi .org/10.1002/prot.20660.
21. Pérez R, Castellanos M, Rodríguez-Huete A, Mateu MG. 2011. Molecular determinants of self-association and rearrangement of a trimeric intermediate during the assembly of a parvovirus capsid. J. Mol. Biol. 413: 32-40. http://dx.doi.org/10.1016/j.jmb.2011.08.020.
22. Doel TR, Pullen L. 1990. International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them. Vaccine 8:473-478. http://dx.doi.org/10.1016/0264-410X(90)90249-L.
23. Rodriguez LL, Gay CG. 2011. Development of vaccines toward the global control and eradication of foot-and-mouth disease. Expert Rev. Vaccines 10:377-387. http://dx.doi.org/10.1586/erv.11.4.
24. Mateo R, Luna E, Rincon V, Mateu MG. 2008. Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines. J. Virol. 82:12232-12240. http: //dx.doi.org/10.1128/JVI.01553-08.
25. Mateu MG, Rocha E, Vicente O, Vayreda F, Navalpotro C, Andreu D, Pedroso E, Giralt E, Enjuanes L, Domingo E. 1987. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res. 8:261-274. http://dx.doi.org/10.1016/0168-1702(87)90020-7.
26. Goodwin S, Tuthill TJ, Arias A, Killington RA, Rowlands DJ. 2009. Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner. J. Virol. 83:11275-11282. http://dx.doi.org/10.1128/JVI.01263-09.